APOE ε4 is associated with postictal confusion in patients with medically refractory temporal lobe epilepsy

Epilepsy Research

Volumn 81, Issue 2-3, 2008, Pages 220-224

  Chapin, Jessica S ^b   Busch, Robyn M ^b,d   Janigro, Damir ^a   Dougherty, Michelle ^a   Tilelli, Cristiane Q ^a   Lineweaver, Tara T ^c   Naugle, Richard I ^a,b,d   Diaz Arrastia, Ramon ^d   Najm, Imad M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c BUTLER UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

APOE; Apolipoprotein E; Neuronal recovery; Postictal confusion; Seizures; Temporal lobe epilepsy

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; ALLELE; ARTICLE; BRAIN NERVE CELL; CONFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INTRACTABLE EPILEPSY; MALE; POSTICTAL CONFUSION; PRIORITY JOURNAL; RISK; TEMPORAL LOBE EPILEPSY; CHI SQUARE DISTRIBUTION; ELECTROENCEPHALOGRAPHY; GENETICS; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; APOLIPOPROTEIN E4; CHI-SQUARE DISTRIBUTION; CONFUSION; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 53249155929     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.05.003     Document Type: Article

References (36)

1. Alberts M.J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A.M., and Roses A.D. ApoE genotype and survival from intracerebral hemorrhage. Lancet 346 (1995) 575-579
2. Barger S.W., and Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nat. Neurosci. 388 (1997) 878-881
3. Blümcke I., Brockhaus A., Scheiwe C., Rollbrocker H.K.W., Elger C.E., and Wiestler O.D. Apolipoprotein E epsilon4 allele is not associated with early onset temporal lobe epilepsy. Neuroreport 8 (1997) 1235-1237
4. In: Bromfield E.B., Cavazos J.E., and Sirven J.E. (Eds). An Introduction to Epilepsy (2006), American Epilepsy Society, Bethesda, MD
5. Busch R.M., Lineweaver T.T., Naugle R.I., Kim K.H., Gong Y., Tilelli C.Q., Prayson R.A., Bingaman W., Najm I.M., and Diaz-Arrastia R. ApoE-e4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy. Neurology 68 (2007) 409-414
6. Diaz-Arrastia R., Gong Y., Fair S., Scott K.D., Garcia M.C., Carlile M.C., Agostini M.A., and Van Ness P.C. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch. Neurol. 60 (2003) 818-822
7. Egensperger R., Kosel S., von Eitzen U., and Graeber M.B. Microglial activation in Alzheimers disease: association with APOE genotype [abstract]. Brain Pathol. 8 (1998) 439-447
8. Ely E.W., Girard T.D., Shintani A.K., Jackson J.C., Gordon S.M., Thomason J.W.W., Pun B.T., Canonico A.E., Light R.W., Pandharipande P., and Laskowitz D.T. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit. Care Med. 35 (2007) 112-117
9. Epilepsy Foundation, 2007. Epilepsy Terms Glossary. http://www.epilepsyfoundation.org/about/glossary.cfm.
10. Evangelou N., Jackson M., Beeson D., and Palace J. Association of the APOE e4 allele with disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 67 (1999) 203-205
11. Gambardella A., Gotman J., Cendes F., and Andermann F. The relation of spike foci and of clinical seizure characteristics to different patterns of mesial temporal atrophy. Arch. Neurol. 52 (1995) 287-293
12. Gambardella A., Aguglia U., Cittadella R., Romeo N., Sibilia G., LePiane E., Messina D., Manna I., Oliveri R., Zappia M., and Quattrone A. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 40 (1999) 1804-1807
13. Grocott H.P., Newman M.F., El-Moalem H., Bainbridge D., Butler A., and Laskowitz D.T. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 122 (2001) 622-623
14. Guerreiro C., Cendes F., Li L.M., Jones-Gotman M., Andermann F., Dubeau F., Piazzini A., and Feindel W. Clinical patterns of patients with temporal lobe epilepsy and pure amygdalar atrophy. Epilepsia 40 (1999) 453-461
15. Horsburgh K., McCulloch J., Nilsen M., Roses A.D., and Nicoll J.A. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur. J. Neurosci. 12 (2000) 4309-4317
16. Houser C.R. Morphological changes in the dentate gyrus in human temporal lobe epilepsy. Epilepsy Res. 7 Suppl. (1992) 223-234
17. Kinnecom C., Lev M.H., Wendell L., Smith E.E., Rosand J., Frosch M.P., and Greenberg S.M. Course of cerebral amyloid angiopathy-related inflammation. Neurology 68 (2007) 1411-1416
18. Laskowitz D.T., Thekdi A.D., Thekdi S.D., Han S.K., Meyers J.K., Pizzo S.V., and Bennet E.R. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp. Neurol. 167 (2001) 74-85
19. Levi O., Jongen-Relo A.L., Feldon J., Roses A.D., and Michaelson D.M. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13 (2003) 273-282
20. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., and Laskowitz D.T. APOE genotype and an apoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278 (2003) 48529-48533
21. Mahley R.W. Apolipoproetin E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
22. Mahley R.W., Nathan B.P., Bellosa S., and Pitas R.E. Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr. Opin. Lipidol. 6 (1995) 86-91
23. Mahley R.W., Weisgraber K.H., and Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5644-5651
24. Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N., Mahley R.W., and Pitas R.E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270 (1995) 19791-19799
25. Ponomareva N.V., Korovaitseva G.I., and Orgaev E.I. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol. Aging 29 (2008) 819-827
26. Sabo T., Lomnitski L., Nyska A., Beni S., Maronpot R.R., Shohami E., Roses A.D., and Michaelson D.M. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 101 (2000) 879-884
27. Schmidt S., Barcellos L.F., DeSombre K., Rimmler J.B., Lincoln R.R., Bucher P., Saunders A.M., Lai E., Martin E.R., Vance J.M., Oksenberg J.R., Hauser S.L., Pericak-Vance M.A., and Haines J.L. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am. J. Human Genet. 70 (2002) 708-717
28. Sheng H., Laskowitz D.T., Bennett E., Schmechel D.E., Bart R.D., Saunders A.M., Pearlstein R.D., Roses A.D., and Warner D.S. Apolipoprotein E isoformspecific differences in outcome from focal ischemia in transgenic mice. J. Cerebr. Blood Flow Metab. 18 (1998) 361-366
29. Sorbi S., Nacmias B., Piacentini S., Repice A., Latorraca S., Forleo P., and Amaducci L. ApoE as a prognostic factor for post-traumatic coma. Natl. Med. 1 (1995) 852
30. Sporiš D., Sertic J., Henigsberg N., Mahovic D., Bogdanovic N., and Babic T. Association of refractory complex partial seizures with a polymorphism of ApoE genotype. J. Cell. Mol. Med. 9 (2005) 698-703
31. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.M., Jakes R., Alberts M.J., Gilbert J.R., Han S., Hulette C., Einstein G., Schmechel D.E., Pericak-Vance M.A., and Roses A.D. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125 (1994) 163-171
32. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., and Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8098-8102
33. Tardiff B.E., Newman M.F., Saunders A.M., Strittmatter W.J., Blumenthal J.A., White W.D., Croughwell N.D., Davis Jr. R.D., Roses A.D., and Reves J.G. Preliminary report of a genetic basis for cognitive declnie after cardiac operations. Ann. Thorac. Surg. 64 (1997) 715-720
34. Teasdale G.M., Nicoll J.A., Murray G., and Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350 (1997) 1069-1071
35. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
36. Yeni S.N., Özkara C., Buyru N., Baykara O., Hanoglu L., Karaagac N., Özyurt E., and Uzan M. Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur. J. Neurol. 12 (2005) 103-107